SBS — Stratec SE Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Stratec SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	250	287	275	270	258
Cost of Revenue
Gross Profit	69	87.7	79.5	68.2	76.4
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	216	239	233	245	230
Operating Profit	33.7	48.2	41.1	25.7	27.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	33	46.8	39.1	21.5	22
Provision for Income Taxes
Net Income After Taxes	28.4	40	29.2	15.4	16
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	25.2	40	29.2	15.4	16
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	25.2	40	29.2	15.4	16
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.34	3.35	2.43	1.37	1.52
Dividends per Share